Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Supporters often highlight the potential for significant therapeutic gains, particularly in conditions where conventional treatments have proven ineffective. However, crucially important to consider the significant financial burden associated with CPI st